Abbott Labs

Abbott and NIH Join Forces to Advance Neuroscience Research
Abbott and NIH Join Forces to Advance Neuroscience Research
Medical Devices and Diagnostics Industry
Abbott Labs
NIH
devices
chronic pain
R&D
Parkinson's Disease
Flag link:
Abbott Labs Starts 2019 Off by Beating Expectations
Abbott Labs Starts 2019 Off by Beating Expectations
Motley Fool
devices
Abbott Labs
earnings
Flag link:
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Wave Life Sciences
Sarepta Therapeutics
Novavax
ContraFect
Scynexis
earnings
Abbott Labs
Intuitive Surgical
Brainsway
Hookipa
Turning Point Therapeutics
IPOs
Flag link:
ACC 2019: Abbott touts reduced stroke, bleeding and pump-clotting in HeartMate 3 trial
ACC 2019: Abbott touts reduced stroke, bleeding and pump-clotting in HeartMate 3 trial
Mass Device
Abbott Labs
devices
HeartMate 3
American College of Cardiology
strokes
Flag link:
Livongo preps for $1B IPO
Livongo preps for $1B IPO
Drug Delivery Business News
Livongo
IPOs
digital health
diabetes
Abbott Labs
Flag link:
Abbott Offers up Rapid Influenza Diagnostic
Abbott Offers up Rapid Influenza Diagnostic
Medical Devices and Diagnostics Industry
Abbott Labs
diagnostics
Flu
BiaxNow
Flag link:
Biotronik wins FDA nod for Orsiro DES
Biotronik wins FDA nod for Orsiro DES
Drug Delivery Business News
devices
Biotronik
FDA
Orsiro
drug-eluting stents
Abbott Labs
Xience
Flag link:
Abbott touts real-world data for FreeStyle Libre glucose monitor
Abbott touts real-world data for FreeStyle Libre glucose monitor
Drug Delivery Business News
Abbott Labs
real world evidence
real world data
FreeStyle Libre
blood glucose monitoring
devices
diabetes
Flag link:
Abbott, Novo Nordisk ink deal for digital diabetes tools
Abbott, Novo Nordisk ink deal for digital diabetes tools
Drug Delivery Business News
Abbott Labs
Novo Nordisk
digital health
digital pharma
insulin
diabetes
FreeStyle Libra
devices
connected insulin pen
Flag link:
Leadership In An Age Of Disruption: Q&A With Abbott Chairman And CEO Miles White
Leadership In An Age Of Disruption: Q&A With Abbott Chairman And CEO Miles White
Forbes
Abbott Labs
Miles White
Pharma CEOs
Flag link:
Is There a Diagnostic Company to Rise From the Ashes of Theranos?
Is There a Diagnostic Company to Rise From the Ashes of Theranos?
BioSpace
diagnostics
Theranos
Guardant Health
Karius
Freenome
Apostle
Grail
liquid biopsy
Genalyte
Abbott Labs
Athelus
Flag link:
Has Abbott's Acquisitive Miles White Made His Last Big Deal?
Has Abbott's Acquisitive Miles White Made His Last Big Deal?
Forbes
Abbott Labs
Pharma CEOs
Miles White
M&A
Flag link:
Abbott misses Wall Street expectations on Q4 sales
Abbott misses Wall Street expectations on Q4 sales
Mass Device
Abbott Labs
devices
earnings
Flag link:
Abbott to acquire mitral valve device maker Cephea Valve Tech
Abbott to acquire mitral valve device maker Cephea Valve Tech
Mass Device
devices
Abbott Labs
mitral valve
Cephea Valve Technologies
M&A
Flag link:
Abbott, AbbVie settle TriCor marketing case for $25 million
Abbott, AbbVie settle TriCor marketing case for $25 million
Yahoo/Reuters
Abbott Labs
AbbVie
kickbacks
TriCor
Flag link:
Report: Abbott CEO White selects possible successor
Report: Abbott CEO White selects possible successor
Mass Device
devices
Abbott Labs
Miles White
Robert Ford
Flag link:
Roche leaves Abbott in the dust when it comes to US approval times
Roche leaves Abbott in the dust when it comes to US approval times
EP Vantage
devices
FDA
device approvals
Roche
Abbott Labs
Becton Dickinson
Flag link:
Abbott alleges ex-marketing exec lifted its neuromod marketing playbook
Abbott alleges ex-marketing exec lifted its neuromod marketing playbook
Mass Device
Abbott Labs
devices
neuromodulation
Nevro
Flag link:
Abbott-Alere One Year Later: Was It Worth All the Fuss?
Abbott-Alere One Year Later: Was It Worth All the Fuss?
Medical Devices and Diagnostics Industry
Abbott Labs
Alere
devices
M&A
Flag link:
Abbott CEO on Libre: ‘We’re just getting started’
Abbott CEO on Libre: ‘We’re just getting started’
Drug Delivery Business News
Abbott Labs
FreeStyle Libre
diabetes
devices
blood glucose monitoring
Flag link:

Pages